Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:06:43.913Z.
Calculation as of: 2026-10-06T17:06:43.913Z.
Quote observation: 2026-10-06T16:54:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4a3a0e03002c1ec33ed026058caacdcc2374dd3411b27b5cd001974e391cfa1f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Edesa Biotech, Inc.
Market Cap
$37.60M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.72M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.08M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.61M
Operating Cash Flow Yield
1.68%
TTM Avg
21.41%
3Y Avg
13.95%
5Y Avg
10.59%
Market Cap
$36.28M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.80M
Operating Cash Flow Yield
N/A
TTM Avg
53.98%
3Y Avg
44.70%
5Y Avg
26.51%
Market Cap
$40.06M
Operating Cash Flow Yield
N/A
TTM Avg
4.07%
3Y Avg
3.32%
5Y Avg
3.32%
Market Cap
$40.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.60M | N/A | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $37.72M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $37.08M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | 1.68% | 21.41% | 13.95% | 10.59% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.80M | N/A | 53.98% | 44.70% | 26.51% |
| Nephros, Inc. (NEPH)vs › | $40.06M | N/A | 4.07% | 3.32% | 3.32% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.09M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.76M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
